Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Nov 2019
Historique:
received: 14 10 2019
revised: 28 10 2019
accepted: 04 11 2019
entrez: 10 11 2019
pubmed: 11 11 2019
medline: 6 5 2020
Statut: epublish

Résumé

One of the major neurodegenerative features of Alzheimer's disease (AD) is the presence of neurotoxic amyloid plaques composed of amyloid beta peptide (Aβ). β-Secretase (BACE1) and acetylcholinesterase (AChE), which promote Aβ fibril formation, have become attractive therapeutic targets for AD. P-glycoprotein (P-gp), the major efflux pump of the blood-brain barrier (BBB), plays a critical role in limiting therapeutic molecules. In pursuit of discovering a natural anti-AD candidate, the bioactivity, physicochemical, drug-likeness, and molecular docking properties of baicalein, a major compound from

Identifiants

pubmed: 31703329
pii: nu11112694
doi: 10.3390/nu11112694
pmc: PMC6893645
pii:
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 1 0
Cholinesterase Inhibitors 0
Flavanones 0
Recombinant Proteins 0
baicalein 49QAH60606
Acetylcholinesterase EC 3.1.1.7
Amyloid Precursor Protein Secretases EC 3.4.-
Aspartic Acid Endopeptidases EC 3.4.23.-
BACE1 protein, human EC 3.4.23.46

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Dong-A University
ID : Not applicable

Références

Neuropsychiatr Dis Treat. 2016 Dec 09;12:3145-3152
pubmed: 28003750
Food Chem Toxicol. 2014 Feb;64:27-33
pubmed: 24291393
CNS Drugs. 2017 Aug;31(8):639-652
pubmed: 28634902
J Pharm Biomed Anal. 2014 Aug;97:9-23
pubmed: 24803030
Biochim Biophys Acta. 2012 Jun;1822(6):885-96
pubmed: 22306812
Nutrients. 2019 Mar 19;11(3):
pubmed: 30893825
Br J Pharmacol. 2002 Dec;137(8):1314-20
pubmed: 12466241
Mol Cell Biol. 2008 Jun;28(11):3663-71
pubmed: 18378702
J Biol Chem. 2001 Jun 29;276(26):23282-7
pubmed: 11313335
J Mol Neurosci. 2010 Mar;40(3):311-20
pubmed: 19731100
EMBO Mol Med. 2016 Jun 01;8(6):595-608
pubmed: 27025652
Biopharm Drug Dispos. 2011 Nov;32(8):427-45
pubmed: 21928297
PLoS One. 2015 Aug 28;10(8):e0136397
pubmed: 26317778
Biomed Pharmacother. 2017 Nov;95:1021-1032
pubmed: 28922719
CNS Neurol Disord Drug Targets. 2014;13(8):1432-9
pubmed: 25345511
Clin Drug Investig. 2016 Sep;36(9):713-724
pubmed: 27352310
Molecules. 2018 Jun 22;23(7):
pubmed: 29932100
J Agric Food Chem. 2004 Jun 30;52(13):4128-32
pubmed: 15212458
Fitoterapia. 2012 Apr;83(3):532-40
pubmed: 22245084
J Neurochem. 2014 Jul;130(1):4-28
pubmed: 24646365
Neuroreport. 2001 Jul 20;12(10):2199-202
pubmed: 11447334
Biol Pharm Bull. 2003 Jan;26(1):79-83
pubmed: 12520178
J Pharm Pharmacol. 2000 Dec;52(12):1563-8
pubmed: 11197087
Bioorg Med Chem Lett. 2011 May 15;21(10):2945-8
pubmed: 21511472
Essays Biochem. 2011 Sep 7;50(1):161-78
pubmed: 21967057
J Neurosci Res. 2013 Sep;91(9):1239-46
pubmed: 23686791
Adv Drug Deliv Rev. 1995 Jul;15(1-3):5-36
pubmed: 35524389
FEBS J. 2008 Feb;275(4):625-32
pubmed: 18205831
FASEB J. 2011 Feb;25(2):775-84
pubmed: 21059748
Nat Rev Neurosci. 2002 Apr;3(4):281-90
pubmed: 11967558
Behav Brain Res. 2016 Sep 15;311:309-321
pubmed: 27233830
Pharm Res. 2011 May;28(5):943-8
pubmed: 20967491
J Neurochem. 2007 Feb;100(3):802-9
pubmed: 17156133
Br J Pharmacol. 2008 Dec;155(8):1279-96
pubmed: 18776918
Hum Mol Genet. 2001 Jun 1;10(12):1317-24
pubmed: 11406613
Inorg Chem. 2018 Jul 2;57(13):7524-7535
pubmed: 29893118

Auteurs

Jin Han (J)

Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Korea.
Center for Silver-Targeted Biomaterials, Brain Busan 21 Plus Program, Graduate School, Dong-A University, Busan 49315, Korea.

Yeongseon Ji (Y)

Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Korea.
Center for Silver-Targeted Biomaterials, Brain Busan 21 Plus Program, Graduate School, Dong-A University, Busan 49315, Korea.

Kumju Youn (K)

Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Korea.

GyuTae Lim (G)

Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
Department of Bioinformatics, KRIBB School of Bioscience, Korea University of Sciences and Technology, Daejeon 34113, Korea.

Jinhyuk Lee (J)

Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Korea.
Department of Bioinformatics, KRIBB School of Bioscience, Korea University of Sciences and Technology, Daejeon 34113, Korea.

Dong Hyun Kim (DH)

Department of Medicinal Biotechnology, College of Health Sciences, Dong-A University, Busan 49315, Korea.
Institute of Convergence Bio-Health, Dong-A University, Busan 49315, Korea.

Mira Jun (M)

Department of Food Science and Nutrition, College of Health Sciences, Dong-A University, Busan 49315, Korea.
Center for Silver-Targeted Biomaterials, Brain Busan 21 Plus Program, Graduate School, Dong-A University, Busan 49315, Korea.
Institute of Convergence Bio-Health, Dong-A University, Busan 49315, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH